bioingenium

One of the key benefits of working with a CDMO is that it enables pharmaceutical companies to focus on drug discovery and commercialization while outsourcing the complex and highly regulated process of biological production. The ability to scale up production rapidly is crucial in the biopharmaceutical industry, particularly when producing proteins or enzymes required for life-saving treatments. As the demand for biologics continues to increase, biopharmaceutical CDMOs are playing an indispensable role in ensuring that therapies are produced efficiently and with the highest standards of quality. A Bacterial expression system is commonly used by a Biopharmaceutical CDMO to produce proteins, with Pichia Pastoris being a popular yeast alternative for expression, and Streptolysin serving as an example of a toxin protein that can be studied using these systems.